March 18, 2016 News by Patricia Silva, PhD Blood Biomarkers of Multiple Sclerosis May Predict a Person’s Response to Treatment Blood biomarkers in individual multiple sclerosisĀ patientsĀ mayĀ help clinicians determine which treatments would be ofĀ mostĀ benefit to that person, according to researchersĀ atĀ Oklahoma Medical Research FoundationĀ (OMRF). The study, published in the journalĀ Neurology, Neuroimmunology & Neuroinflammation, isĀ titled “Cytokine profiles show heterogeneity of interferon-Ī² response in multiple sclerosis patients.”…
September 28, 2015 News by Patricia Silva, PhD EMD Serono To Present New Data on Rebif, a Therapy for RRMS, at Upcoming ECTRIMS Congress EMD Serono, the subsidiary of Merck KGaA in the United States, recently announced that it will present new data on RebifĀ®, an interferon beta-1a therapy for relapsing-remitting multiple sclerosis (RRMS), at the upcoming 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), to be…
June 8, 2015 News by Patricia Silva, PhD Review Suggests PEG-IFN Therapy for Relapsing-Remitting Multiple Sclerosis Significantly Reduces Relapse Rates A study recently published in the journal PLoS One compared the use of a specific treatment based on interferon beta-1a with other approved injectable therapies in patients with relapsing-remitting multiple sclerosis (RRMS). The study is entitled āA Network Meta-Analysis of Efficacy and Evaluation of…
May 18, 2015 News by Patricia Silva, PhD New Genetic Variant as Predictor of Patients’ Response to MS Treatment A team led by researchers at San Raffaele Scientific Institute in Italy andĀ Brigham and Women’s Hospital in Boston, Massachusetts recently revealed a new genetic variant linked to multiple sclerosis (MS). The study is entitled āA pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activityā and isĀ published in…
April 1, 2015 News by Patricia Silva, PhD Statins Therapy in Multiple Sclerosis Yields Controversial Results Researchers at the IRCCS Centro Neurolesi āBonino-Pulejoā and the University of Messina in Italy have performed a review on the immunomodulatory activity reported for statins in the treatment of multiple sclerosis (MS) and on clinical trial results. The study was published in the journal Pharmacological…